Covered recipient · General Payments record
ZENOBIO AGUILA
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2019–2025
$3,209.37
- Reported across 196 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $251.67 | 11 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Exact Sciences Corporation | $54.57 | 2 |
| Novo Nordisk AS | $51.01 | 2 |
| Acerta Pharma LLC | $42.11 | 2 |
| Amgen Inc. | $35.33 | 2 |
| ABBVIE INC. | $34.10 | 1 |
| Astellas Pharma US Inc | $20.22 | 1 |
| Merck Sharp & Dohme Corporation | $14.33 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $34.10 | 04/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201373579 | CMS |
| Amgen Inc. | $16.90 | 03/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228379498 | CMS |
| Amgen Inc. | $18.43 | 08/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228379500 | CMS |
| Astellas Pharma US Inc | $20.22 | 09/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238670061 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.46 | 02/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1207264857 | CMS |
| AstraZeneca Pharmaceuticals LP | $28.65 | 08/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1206863069 | CMS |
| Exact Sciences Corporation | $27.16 | 04/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235460449 | CMS |
| Exact Sciences Corporation | $27.41 | 09/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235460457 | CMS |
| Merck Sharp & Dohme LLC | $14.33 | 03/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238314706 | CMS |
| Novo Nordisk Inc | $24.27 | 03/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188819285 | CMS |
| Novo Nordisk Inc | $26.74 | 07/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188737054 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.